Dexmedetomidine Versus Midazolam for Peribulbar Block
Status:
COMPLETED
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
50 patients of both sexes, ages 18 to 75, who were scheduled for cataract surgery and had physical status I or II according to the American Society of Anesthesiologists were included in this study.
After induction of general anesthesia, all patients received peribulbar block. In group A (midazolam group), 25 patients received midazolam. In group B (dexmedetomidine group), 25 patients received dexmedetomidine.